Brown Brothers Harriman & Co. Makes New $32,000 Investment in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Brown Brothers Harriman & Co. acquired a new stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 2,000 shares of the company’s stock, valued at approximately $32,000.

A number of other hedge funds also recently made changes to their positions in BMEZ. Dakota Wealth Management increased its stake in BlackRock Health Sciences Term Trust by 5.3% in the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after acquiring an additional 915 shares during the last quarter. Oppenheimer & Co. Inc. increased its position in shares of BlackRock Health Sciences Term Trust by 0.6% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock valued at $3,237,000 after purchasing an additional 1,153 shares during the last quarter. Brown Lisle Cummings Inc. raised its holdings in shares of BlackRock Health Sciences Term Trust by 6.2% during the 3rd quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock valued at $578,000 after buying an additional 2,128 shares in the last quarter. Comerica Bank lifted its position in BlackRock Health Sciences Term Trust by 31.1% in the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after buying an additional 3,671 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. boosted its stake in BlackRock Health Sciences Term Trust by 11.2% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 65,088 shares of the company’s stock worth $1,000,000 after buying an additional 6,565 shares in the last quarter.

BlackRock Health Sciences Term Trust Trading Up 1.0 %

Shares of NYSE BMEZ opened at 15.56 on Friday. BlackRock Health Sciences Term Trust has a one year low of 13.72 and a one year high of 16.59. The firm’s 50 day simple moving average is 15.66 and its two-hundred day simple moving average is 15.59.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be given a $0.1769 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 13.64%. The ex-dividend date is Friday, November 15th.

Insiders Place Their Bets

In related news, major shareholder Saba Capital Management, L.P. purchased 15,455 shares of the firm’s stock in a transaction on Thursday, September 19th. The shares were acquired at an average cost of 16.14 per share, with a total value of 249,443.70. Following the purchase, the insider now directly owns 20,601,568 shares of the company’s stock, valued at approximately 332,509,307.52. This trade represents a 0.08 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders acquired 99,630 shares of company stock valued at $1,585,113 over the last three months.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.